AstraZeneca to Invest $2B in Maryland

Breaking News
Collaborations & Alliances

BioMed X, AbbVie Launch New Research Project Focused on Anhedonia

Researchers are invited to submit proposals for innovative research projects aimed at uncovering the entangled microcircuits and molecular targets disrupted in anhedonia.

SPONSOR

Speed & Flexibility: The New CDMO Advantage

Pharma’s future demands faster, more agile partners. See how leading CDMOs like ROIS are adapting to shifting market and regulatory needs.

Breaking News
Collaborations & Alliances

AGC Biologics Enters Gene Therapy Manufacturing Agreement with AAVantgarde

AGC Biologics to provide GMP manufacturing for AAVantgarde’s two novel candidates designed to address progressive and irreversible vision loss.

Breaking News
Trials & Filings

EU Clears Bristol Myers Squibb’s Breyanzi for Mantle Cell Lymphoma

Marks Breyanzi’s fourth indication in Europe, adding to existing approvals for several aggressive B-cell lymphomas.

SPONSOR

Next-Generation Topical Approach: A Breakthrough in Liposome-Integrated Formulations

Topical delivery is evolving. Discover how liposome-integrated formulations enhance penetration, retention & therapeutic effect.

Breaking News

Sanofi and Regeneron’s Dupixent Approved in EU

Approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria.

SPONSOR

Decentralized Clinical Trials Outlook

In this eBook from Contract Pharma and IQVIA, explore the importance of fine-tuning patient-centered DCT solutions with evolving site roles and perspectives in mind.

Solution Content Center SPOTLIGHT

Sofgen CDMO

Sofgen Pharma is a leading integrated healthcare and pharmaceutical company that develops and manufactures pharmaceutical and nutraceutical solutions. They have a direct presence in 13 countries - Bolivia, Brazil, Colombia, Costa Rica, Dominican Republic, Ecuador, El Salvador, Guatemala, Honduras, Nicaragua, Panama, Peru, and United States with customers located in over 50 countries.